The most competitive companies in the pharmaceutical business will compete in the diabetic medicine market

Published: 2014-10-08 11:11:01

Updated: 2014-10-08 11:11:01

The Korean pharmaceutical companies, such as CJ, Yuhan Corporation, Daewoong Pharm Co., will compete in the diabetic medicine market of SGLT-2 inhibitors.

As Astrazeneca(Forxiga), Boehringer Ingelheim(Jardiance), and Astellas(Suglat) made strategic partnerships to sell SGLT-2 inhibitors with CJ, Yuhan Corporation and Daewoon Pharm Co. respectively, it becomes a battle of marketing agencies be...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.